Artiva Biotherapeutics, Inc. Common Stock (ARTV) — Financial Flexibility Index
Artiva Biotherapeutics, Inc. Common Stock (ARTV) has a Financial Flexibility Index of -0.95x as of September 2025. Free cash flow of $-18.60 Million (operating CF $-19.20 Million minus capex $600.00K) represents -1% of total liabilities ($19.64 Million). Check how tangible is Artiva Biotherapeutics, Inc. Common Stoc's equity to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Artiva Biotherapeutics, Inc. Common Stock Financial Flexibility Index (2020–2024)
Historical Financial Flexibility Index trend for Artiva Biotherapeutics, Inc. Common Stock across 5 annual periods. For the full cash flow conversion analysis, see ARTV operating cash flow.
Annual Financial Flexibility Index for Artiva Biotherapeutics, Inc. Common Stock (2020–2024)
Year-by-year free cash flow to debt coverage for Artiva Biotherapeutics, Inc. Common Stock. Explore Artiva Biotherapeutics, Inc. Common Stoc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.37x | $-54.39 Million | $-55.03 Million | $22.94 Million | ▼ -1333.8% |
| 2023 | -0.17x | $-44.17 Million | $-47.43 Million | $267.13 Million | ▼ -1.7% |
| 2022 | -0.16x | $-44.53 Million | $-50.83 Million | $273.75 Million | ▼ -210.0% |
| 2021 | -0.05x | $-13.58 Million | $-15.30 Million | $258.78 Million | ▲ +79.9% |
| 2020 | -0.26x | $-13.26 Million | $-13.54 Million | $50.80 Million | — |